SmarterDividends

LLY vs MRNA: Which Is the Better Dividend Stock?

As of Nov 1, 2026, LLY (Eli Lilly and Company) screens as the stronger dividend stock, winning 3 of 4 head-to-head metrics. LLY offers the higher yield at 0.49%, LLY has the higher dividend-safety score.

Key facts: LLY vs MRNA

Data as of · Source: SmarterDividends data

  • As of Nov 1, 2026, Eli Lilly and Company (LLY) has the higher forward dividend yield at 0.49%, versus 0.00% for Moderna, Inc. (MRNA).
  • By SmarterDividends' count as of Nov 1, 2026, LLY has raised its dividend for 11 consecutive years and MRNA for 0.
Cite this page

SmarterDividends, "LLY vs MRNA: Dividend Yield, Safety & Value Compared," updated Nov 1, 2026, https://smarterdividends.com/compare/lly-vs-mrna

MetricLLYMRNA
Forward yield0.49%0.00%
Annual dividend$6.92$0.00
Payout ratio22%0%
Years of growth11 yr0 yr
5-yr dividend growth15.2%—
5-yr total return471%—
Dividend safety score94 (A)—
Fair value estimate$804.91—
Upside to fair value-43%—
Frequencyquarterly—
Market cap$1.3T$88.5B
P/E ratio45.8—

Higher yield

LLY

0.49%

Safer dividend

LLY

Grade A

Faster growth

LLY

15.2%

LLY vs MRNA — FAQ

Is LLY or MRNA a better dividend stock?

On the data, LLY wins more head-to-head categories (3 vs 1). LLY offers the higher yield (0.49%), while LLY has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, LLY or MRNA?

LLY has the higher forward dividend yield at 0.49%, versus 0.00% for MRNA.

Is LLY or MRNA safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.